The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
VolitionRx (VNRX) announces the results of a study which shows that an automated Nu.Q Cancer immunoassay test in development detected a range ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ('Volition'), a multi-national epigenetics company, today announces the results of a study which shows that an automated Nu.Q® Cancer immunoassay test in ...
VolitionRx (VNRX) announced the expansion of its Nu.Q Vet Cancer Test supply agreement with Fujifilm Vet Systems in Japan, to include ...
Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...
Bert Janssens takes the Europe spot and Eric Liu takes North America. Franzén, who succeeds Christian Sinding as CEO ...
Archimed has bought BioVendor, with plans to build and internationalize the Czech diagnostics company. Archimed sees ...
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) ...
It is aimed at stopping terrorism and radicalisation, but devastating attacks and high-profile reviews have meant Prevent has been under scrutiny since it started. The government programme has ...
President Donald Trump correctly noted Friday, as he has before, that Canada has tariffs above 200% on dairy products imported from the US. But Trump again failed to mention a critical fact. Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback